138 related articles for article (PubMed ID: 8782170)
1. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast.
Heiberg EV; Perman WH; Herrmann VM; Janney CG
Magn Reson Imaging; 1996; 14(4):337-48. PubMed ID: 8782170
[TBL] [Abstract][Full Text] [Related]
2. A fast 3D-imaging technique for performing dynamic Gd-enhanced MRI of breast lesions.
Perman WH; Heiberg EM; Grunz J; Herrmann VM; Janney CG
Magn Reson Imaging; 1994; 12(4):545-51. PubMed ID: 8057758
[TBL] [Abstract][Full Text] [Related]
3. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
[TBL] [Abstract][Full Text] [Related]
4. [MR imaging for breast cancer].
Seki T; Hachiya J; Nitatori T; Yokoyama K; Fukushima H; Uchigasaki S
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):347-56. PubMed ID: 8709936
[TBL] [Abstract][Full Text] [Related]
5. Half-Fourier, three-dimensional technique for dynamic contrast-enhanced MR imaging of both breasts and axillae: initial characterization of breast lesions.
Perman WH; Heiberg EV; Herrmann VM
Radiology; 1996 Jul; 200(1):263-9. PubMed ID: 8657924
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions.
den Boer JA; Hoenderop RK; Smink J; Dornseiffen G; Koch PW; Mulder JH; Slump CH; Volker ED; de Vos RA
J Magn Reson Imaging; 1997; 7(4):702-15. PubMed ID: 9243392
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
8. Limitations of the keyhole technique for quantitative dynamic contrast-enhanced breast MRI.
Bishop JE; Santyr GE; Kelcz F; Plewes DB
J Magn Reson Imaging; 1997; 7(4):716-23. PubMed ID: 9243393
[TBL] [Abstract][Full Text] [Related]
9. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced magnetic resonance imaging of the breast.
Heywang-Köbrunner SH
Invest Radiol; 1994 Jan; 29(1):94-104. PubMed ID: 8144345
[No Abstract] [Full Text] [Related]
11. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
12. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer.
Fischer U; Kopka L; Brinck U; Korabiowska M; Schauer A; Grabbe E
Eur Radiol; 1997; 7(7):1002-5. PubMed ID: 9265662
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
15. Computed model of gadolinium enhanced MRI of breast disease.
Kenney PJ; Sobol WT; Smith JK; Morgan DE
Eur J Radiol; 1997 Feb; 24(2):109-19. PubMed ID: 9097052
[TBL] [Abstract][Full Text] [Related]
16. [Three-dimentional volumetric interpolated breath-hold magnetic resonance imaging for the diagnosis of breast tumors].
Nakayama S; Kakizaki D; Kaise H; Kusama M; Ishikawa A; Amino M; Koyanagi Y; Abe K; Iwaya K
Nihon Rinsho; 2004 Apr; 62(4):790-8. PubMed ID: 15106351
[TBL] [Abstract][Full Text] [Related]
17. Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography?
Müller-Schimpfle M; Stoll P; Stern W; Kurz S; Dammann F; Claussen CD
AJR Am J Roentgenol; 1997 May; 168(5):1323-9. PubMed ID: 9129436
[TBL] [Abstract][Full Text] [Related]
18. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
19. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
[TBL] [Abstract][Full Text] [Related]
20. MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA.
Crisci R; Di Cesare E; Lupattelli L; Coloni GF
Eur J Cardiothorac Surg; 1997 Feb; 11(2):214-7. PubMed ID: 9080145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
